drugset / Trial / NCT01457716

Pharmacokinetic Pilot Study on Budesonide/Formoterol

NCT01457716

Completed 17 enrolled Orion Corporation, Orion Pharma
RandomizedCrossoverOpen-label

Summary

The aim of the study is to assess and compare the Pharmacokinetic (PK) of Budesonide and Formoterol after administration of 3 different product variants of Budesonide/Formoterol Easyhalers and Symbicort turbuhaler.

Timeline

Start
2011-10
Primary completion
2011-11
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide Small molecule Inhaled
Subject Formoterol Other / unclassified Inhaled

Indications

No indication recorded.